Clinical Trial Update: Health Evaluation in African Americans Using RAS Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating safety and health outcomes of RAS Therapy in African American individuals with Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• RAS Therapy

Snippet

Sponsor: Emory University | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-23